Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Sionna Therapeutics, Inc. (SION) Institutional Ownership & Insider Trading

146 institutions reported holding Sionna Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 143 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SIONSionna Therapeutics, Inc.Follow SION — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
162.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

146 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +5.6%.

Increased+54New+33Decreased-40Closed-6

Largest moves, shares (millions)

Adage Capital Partners Gp+1.4MCasdin Capital+0.4MSiren+0.3MOrbimed Advisors-1.0MDeerfield Management Company-0.3MAberdeen Group-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Mar 25+1.9Jun 25+1.4Sep 25-1.1Dec 25+1.8Mar 26+2.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2614648+5.6%5433406
Mar 2612246+5.2%3928279
Dec 2510044-2.4%3927207
Sep 257745+3.2%2018185
Jun 256543+5.4%1725108
Mar 254741—————

Sionna Therapeutics, Inc. — questions

Who owns Sionna Therapeutics, Inc. stock?
146 institutions reported Sionna Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: RA CAPITAL MANAGEMENT, L.P. (21.9%), TPG GP A, LLC (14.4%), VIKING GLOBAL INVESTORS LP (7.1%).
Are Sionna Therapeutics, Inc. insiders buying or selling?
143 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Sionna Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.